Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immune Checkpoint Inhibitor Toxicity (I-CHECKIT): A Prospective Observational Study

NCT04871542 is registered in ClinicalTrials.gov with SWOG Cancer Research Network as lead sponsor.

NCT NCT04871542
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04871542 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immune Checkpoint Inhibitor Toxicity (I-CHECKIT): A Prospective Observational Study
Lead sponsor
SWOG Cancer Research Network
Phase
Observational
Overall status
Recruiting
Start date
September 13, 2021
Completion date
March 14, 2028
Enrollment
2,062 (estimated)
Sites
849

Conditions

As the registry lists them; a condition with its own page is linked.

malignant solid neoplasm